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This article has been corrected: The image for #4-3 in Figure 2C is incorrect. It is a duplicate image of panel #4-2. The 
corrected Figure 2C is shown below. The authors declare that these corrections do not change the results or conclusions of 
this paper.
 Correction
Original article: Oncotarget. 2017; 8:39087-39100. https://doi.org/10.18632/oncotarget.16598
Figure 2: CYP1B1 inhibition suppresses in vitro tumorigenicity. (A and B) Expression of CYP1B1 mRNA (A) and protein (B) in 
CYP1B1 shRNA or control shRNA expressing PC-3 cells. Levels were determined by qRT-PCR and Western blot, respectively. (C–H) Effect 
of CYP1B1 knockdown on in vitro tumorigenicity. Cell proliferation as determined by MTS assay at the indicated times. Representative 
images of cell morphology (left panel) and quantification of cell proliferation (right panel) are shown (C). Colony formation as determined 
by crystal violet staining. Representative image of colonies (left panel) and quantification of stained colonies (right panel) are shown (D). 
Apoptotic cell death as determined by flow cytometric analysis using double staining with Annexin V-FITC and 7-AAD. Representative 
biparametric histograms exhibiting cell (left panel) and quantification of apoptotic cells (right panel) are shown (E). Cell cycle progression 
as determined by DAPI staining (F). Cell migration (G) and invasion (H) capability as determined by transwell migration and invasion 
assay, respectively. Representative images (left panel) and quantification of assay (right panel) are shown. **p<0.01; ***p<0.001.
